C. Buddy Creech

15.5k total citations · 3 hit papers
118 papers, 3.5k citations indexed

About

C. Buddy Creech is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, C. Buddy Creech has authored 118 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Infectious Diseases, 52 papers in Epidemiology and 36 papers in Public Health, Environmental and Occupational Health. Recurrent topics in C. Buddy Creech's work include Antimicrobial Resistance in Staphylococcus (43 papers), Streptococcal Infections and Treatments (28 papers) and Influenza Virus Research Studies (25 papers). C. Buddy Creech is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (43 papers), Streptococcal Infections and Treatments (28 papers) and Influenza Virus Research Studies (25 papers). C. Buddy Creech collaborates with scholars based in United States, Australia and Canada. C. Buddy Creech's co-authors include Kathryn M. Edwards, Shannon C. Walker, Robert J. Samuels, Isaac Thomsen, Douglas S. Kernodle, Edward H. Livingston, Preeti Malani, Stephanie A. Fritz, Henry F. Chambers and Natalia Jimenez‐Truque and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

C. Buddy Creech

116 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 Vaccines

2021 288 citations C. Buddy Creech, Shannon C. Walker et al. profile →
Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics

2021 114 citations C. Buddy Creech et al. Journal of the Pediatric Infectious Diseases Society profile →
Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children

2022 80 citations Derek J. Williams, C. Buddy Creech et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Buddy Creech United States	33	1.8k	1.2k	781	676	591	118	3.5k
Duane W. Newton United States	31	1.3k 0.7×	1.2k 1.0×	705 0.9×	420 0.6×	370 0.6×	79	3.4k
Mobeen H. Rathore United States	33	1.4k 0.8×	1.5k 1.2×	537 0.7×	216 0.3×	515 0.9×	141	3.7k
Sook‐In Jung South Korea	30	1.8k 1.0×	1.2k 1.0×	333 0.4×	334 0.5×	163 0.3×	166	3.5k
Michal Chowers Israel	26	2.0k 1.1×	864 0.7×	920 1.2×	307 0.5×	406 0.7×	92	3.3k
Eu Suk Kim South Korea	30	2.0k 1.1×	1.0k 0.9×	405 0.5×	403 0.6×	145 0.2×	216	3.9k
Pyoeng Gyun Choe South Korea	32	3.3k 1.8×	1.1k 0.9×	424 0.5×	345 0.5×	176 0.3×	168	4.5k
Lionel Piroth France	37	2.1k 1.1×	2.0k 1.7×	381 0.5×	357 0.5×	152 0.3×	208	4.5k
Tony M. Korman Australia	36	2.6k 1.4×	2.2k 1.9×	596 0.8×	790 1.2×	118 0.2×	157	5.1k
José Marı́a Eiros Bouza Spain	28	1.1k 0.6×	1.5k 1.2×	214 0.3×	500 0.7×	440 0.7×	301	3.3k
Petri Ruutu Finland	43	2.1k 1.2×	2.6k 2.2×	381 0.5×	383 0.6×	401 0.7×	163	5.3k

Countries citing papers authored by C. Buddy Creech

Since Specialization

Citations

This map shows the geographic impact of C. Buddy Creech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Buddy Creech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Buddy Creech more than expected).

Fields of papers citing papers by C. Buddy Creech

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Buddy Creech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Buddy Creech. The network helps show where C. Buddy Creech may publish in the future.

Co-authorship network of co-authors of C. Buddy Creech

This figure shows the co-authorship network connecting the top 25 collaborators of C. Buddy Creech. A scholar is included among the top collaborators of C. Buddy Creech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Buddy Creech. C. Buddy Creech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Healy, Catherine, C. Buddy Creech, Sharon E. Frey, et al.. (2025). 579. Safety and Immunogenicity of Mpox Vaccination in Adolescents. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Frey, Sharon E., Rebecca C. Brady, Lisa A. Jackson, et al.. (2025). Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®. Vaccine. 47. 126702–126702. 1 indexed citations

Creech, C. Buddy, Mariana Leguía, Johannes B. Goll, et al.. (2025). Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccines. npj Vaccines. 10(1). 189–189. 2 indexed citations

Howard, Leigh M., Johannes B. Goll, Casey E. Gelber, et al.. (2024). Metabolomic Signatures Differentiate Immune Responses in Avian Influenza Vaccine Recipients. The Journal of Infectious Diseases. 230(3). 716–725. 2 indexed citations

Creech, C. Buddy, et al.. (2024). Amniotic membrane transplantation as part of a multimodal management approach to Streptococcus pyogenes necrotizing keratoconjunctivitis. Journal of American Association for Pediatric Ophthalmology and Strabismus. 28(3). 103900–103900.

Yoder, Sandra, Rachel S. Nargi, Nurgun Kose, et al.. (2023). Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants. Journal of the Pediatric Infectious Diseases Society. 12(5). 298–305. 1 indexed citations

Walker, Shannon C., Benjamin French, Ryan Moore, et al.. (2023). Model-Guided Decision-Making for Thromboprophylaxis and Hospital-Acquired Thromboembolic Events Among Hospitalized Children and Adolescents. JAMA Network Open. 6(10). e2337789–e2337789. 6 indexed citations

Top, Karina A., Robert T. Chen, Ofer Levy, et al.. (2022). Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. Clinical Infectious Diseases. 75(Supplement_1). S11–S17. 12 indexed citations

Yi, Jumi, James B. Wood, C. Buddy Creech, et al.. (2021). Clinical Epidemiology and Outcomes of Pediatric Musculoskeletal Infections. The Journal of Pediatrics. 234. 236–244.e2. 20 indexed citations

10.

Gilchuk, Iuliia M., Sandhya Bangaru, Pavlo Gilchuk, et al.. (2019). Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice. Cell Host & Microbe. 26(6). 715–728.e8. 44 indexed citations

11.

Frenck, Robert W., C. Buddy Creech, Eric Sheldon, et al.. (2016). Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study. Vaccine. 35(2). 375–384. 51 indexed citations

12.

Thomsen, Isaac, Natalia Jimenez‐Truque, Lauren Jones, et al.. (2016). Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis. Journal of Cystic Fibrosis. 15(5). 597–604. 11 indexed citations

13.

Thomsen, Isaac, et al.. (2016). A Comprehensive Approach to the Management of Children and Adults with Chronic Granulomatous Disease. The Journal of Allergy and Clinical Immunology In Practice. 4(6). 1082–1088. 38 indexed citations

14.

Kotloff, Karen L., Natasha Halasa, Christopher J Harrison, et al.. (2014). Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children. The Pediatric Infectious Disease Journal. 33(8). 865–871. 8 indexed citations

15.

Hammer, Neal D., James E. Cassat, Michael J. Noto, et al.. (2014). Inter- and Intraspecies Metabolite Exchange Promotes Virulence of Antibiotic-Resistant Staphylococcus aureus. Cell Host & Microbe. 16(4). 531–537. 56 indexed citations

16.

Creech, C. Buddy, et al.. (2011). Frequency of Peripherally Inserted Central Catheter Complications in Children. The Pediatric Infectious Disease Journal. 31(5). 519–521. 84 indexed citations

17.

Williams, Derek J., et al.. (2010). Culture-negative Osteoarticular Infections in the Era of Community-associated Methicillin-resistant Staphylococcus aureus. The Pediatric Infectious Disease Journal. 30(6). 523–525. 30 indexed citations

18.

Creech, C. Buddy, et al.. (2010). Procalcitonin as a Marker of Severe Bacterial Infection in Children in the Emergency Department. Pediatric Emergency Care. 26(1). 51–60. 32 indexed citations

19.

Dulek, Daniel E., John V. Williams, C. Buddy Creech, et al.. (2010). Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus. Clinical Infectious Diseases. 50(11). 1493–1496. 50 indexed citations

20.

Krause, Jens C., Pegah Ghandil, Maya Chrabieh, et al.. (2009). Very Late‐Onset Group BStreptococcusMeningitis, Sepsis, and Systemic Shigellosis due to Interleukin‐1 Receptor–Associated Kinase‐4 Deficiency. Clinical Infectious Diseases. 49(9). 1393–1396. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact